TR
Rhelion Life Sciences Corp.
TRUFF · OTC
$0.02 -2.53% (-$0.00)
1M +10.63%
Market Cap $13.6M
P/E Ratio -
Div. Yield -
ROE 43.00%
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap P/S 4.40x
P/B 0.72x
P/E N/A
Growth
23 /100
Declining Rev. growth 2.03%
Book val. growth 22.86%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 36.80%
Net margin 213.37%
Op. margin 263.74%
Quality
2 /100
Poor ROIC 42.04%
ROE 43.00%
ROA 30.04%
Debt
69 /100
Low Debt/Equity 0.02x
Current ratio 3.25x
Int. coverage -97.77x
Stability
47 /100
Moderate Beta 0.96x
Rev. volatility 17.75%
EPS volatility 67.06%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TRUFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Todd Michael Shapiro
Employees
104
Headquarters
Toronto
Evenimente viitoare
30 NOV.
Earnings
Upcoming earnings report